US private equity firm KKR & Co. has agreed to acquire Bengaluru-headquartered Healthium Medtech Ltd from UK private equity firm Apax Partners.

KKR-managed funds will acquire a controlling stake in the Healthium group through a special-purpose vehicle. This investment, facilitated by KKR's Asian Fund IV, represents KKR's latest venture in the healthcare sector in India and the Asia-Pacific region. The acquisition of Healthium is anticipated to be finalized in Q3 of 2024. Established in India in 1992, Healthium is a medical technology company specializing in developing, manufacturing, and global distribution of surgical products. Its diverse portfolio caters to various surgical needs, encompassing wound closure, arthroscopy, and advanced wound care products. Following Apax Partners' acquisition of Healthium in 2018, the company expanded its range of wound closure devices and consumables and ventured into new areas such as arthroscopy and advanced wound care through strategic acquisitions.

Jefferies LLC provided financial advisory services to Apax Partners and Healthium in their recent sale to KKR, while Kirkland & Ellis LLP served as their legal counsel. KKR received financial advisory support from Moelis & Co. and legal counsel from Simpson Thacher & Bartlett and AZB & Partners.